UDP-Glucuronosyltransferases (UGTs) 2B7 and UGT2B17 Display Converse Specificity in Testosterone and Epitestosterone Glucuronidation, whereas UGT2A1 Conjugates Both Androgens Similarly

被引:86
|
作者
Sten, Taina [1 ,2 ]
Bichlmaier, Ingo [2 ]
Kuuranne, Tiia [3 ]
Leinonen, Antti [3 ]
Yli-Kauhaluoma, Jari [2 ]
Finel, Moshe [1 ]
机构
[1] Univ Helsinki, Fac Pharm, CDR, FI-00014 Helsinki, Finland
[2] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, FI-00014 Helsinki, Finland
[3] United Labs Ltd, Doping Control Lab, Helsinki, Finland
基金
芬兰科学院;
关键词
URINARY TESTOSTERONE; 2B17; CONSEQUENCES; XENOBIOTICS; STABILITY; ALCOHOLS; STEROIDS; PROTEIN;
D O I
10.1124/dmd.108.024844
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Testosterone and epitestosterone are endogenous steroids that differ in the configuration of the hydroxyl-bearing carbon at C-17. Testosterone is the predominant male sex hormone, whereas the role of epitestosterone is largely unclear. In humans, both androgens are excreted mainly as glucuronide conjugates and the urinary ratio of testosterone to epitestosterone (T/E), used to expose illicit testosterone abuse by male athletes, indicates the relative concentrations of the respective glucuronides. Some male athletes have T/E values greater than the accepted threshold value (4.0), even without testosterone abuse. We have analyzed athletes' urine samples and found that the main reason for such false-positive results in doping tests was a low epitestosterone glucuronide concentration not a high level of testosterone glucuronide. Sulfate conjugates of both testosterone and epitestosterone were also detected in the different urine samples. Glucuronidation assays with the 19 human UDP-glucuronosyl-transferases (UGTs) of subfamilies UGT1A, UGT2A, and UGT2B revealed that UGT2B17 is the most active enzyme in testosterone glucuronidation. UGT2B17 does not glucuronidate epitestosterone, but inhibition studies revealed that it binds epitestosterone with affinity similar to that of testosterone. Epitestosterone glucuronidation is catalyzed mainly by UGT2B7, and the K-m of this reaction is significantly lower than the K-m of UGT2B17 for testosterone. Although UGT2B7 and UGT2B17 exhibited high, although converse, stereoselectivity in testosterone and epitestosterone glucuronidation, UGT2A1, an extrahepatic enzyme that is expressed mainly in the nasal epithelium, catalyzed the glucuronidation of both steroids at considerable rates and similar kinetics. The results shed new light on the substrate specificity and stereoselectivity of human UGTs.
引用
收藏
页码:417 / 423
页数:7
相关论文
共 50 条
  • [41] Tissue Distribution and Relative Gene Expression of UDP-Glucuronosyltransferases (2B7, 2B15, 2B17) in the Human Fetus
    Ekstrom, Lena
    Johansson, Maria
    Rane, Anders
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (02) : 291 - 295
  • [42] Effect Of UGT1A4 And 2B7 Polymorphisms On Lamotrigine Glucuronidation In Epilepsy Patients
    Petrenaite, V.
    Ohman, I.
    Ekstrom, L.
    Bertilsson, L.
    Jantzen, F. T.
    Saebye, D.
    Tomson, T.
    Sabers, A.
    EPILEPSIA, 2018, 59 : S214 - S214
  • [43] Bovine Serum Albumin Decreases Km Values of Human UDP-Glucuronosyltransferases 1A9 and 2B7 and Increases Vmax Values of UGT1A9
    Manevski, Nenad
    Moreolo, Paolo Svaluto
    Yli-Kauhaluoma, Jari
    Finel, Moshe
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (11) : 2117 - 2129
  • [44] In vitro glucuronidation of mycophenolic acid by human UGTs and the impact of known polymorphisms of UGT1A8, UGT1A9, and UGT2B7
    Bernard, O
    Guillemette, C
    DRUG METABOLISM REVIEWS, 2003, 35 : 53 - 53
  • [45] Glucuronidation of arachidonic acid, 20-hydroxy-eicosatetraenoic acid and prostaglandin E2 by human hepatic and intestinal UDP-glucuronosyltransferases and recombinant UGT2B7
    Sonka, J
    Little, J
    Samokyszyn, V
    Radominska-Pandya, A
    DRUG METABOLISM REVIEWS, 2002, 34 : 194 - 194
  • [46] Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7
    Mroz, Anna
    Ryska, Izabela
    Sominko, Hanna
    Bejrowska, Anna
    Mazerska, Zofia
    PHARMACOLOGICAL REPORTS, 2018, 70 (05) : 972 - 980
  • [47] IS URINARY TESTOSTERONE GLUCURONIDE A POTENTIAL BIOMARKER FOR UGT2B17 ONTOGENY IN AGES 7 TO 18 YEARS?
    Zhang, Haeyoung
    Basit, Abdul
    Leeder, Steven
    Prasad, Bhagwat
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S18 - S18
  • [48] Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7
    Anna Mróz
    Izabela Ryska
    Hanna Sominko
    Anna Bejrowska
    Zofia Mazerska
    Pharmacological Reports, 2018, 70 : 972 - 980
  • [49] Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes
    Liu, Hongming
    Wu, Zhufeng
    Ma, Zhiguo
    Wu, Baojian
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (09) : 513 - 524
  • [50] Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients (vol 10, e0132269, 2015)
    Romero-Lorca, A.
    Novillo, A.
    Gaibar, M.
    Bandres, F.
    Fernandez-Santander, A.
    PLOS ONE, 2015, 10 (10):